2021 ASTRO Annual Meeting (Videos)

2021 ASTRO Annual Meeting (Videos) has been uniquely designed to ensure that attendees from around the globe continue to access timely scientific and educational content. The Presidential Symposium will highlight the meeting theme by taking a deeper dive into how we embrace rapid advancements in the field to provide the best person-centered care in the most efficient ways. New this year is a track dedicated to diversity, equity and inclusion in health care. The PRO and ARRO programs will provide curated content addressing issues specific to community practitioners and residents. Our Cancer Breakthroughs and Science Highlights sessions have been expanded to provide you with the latest science at your fingertips. Storytelling sessions will highlight various topics from patient perspectives to parental leave to data breaches and more. There are over 200 hours of educational content and over 200 CE hours available.

The scientific program is the ideal platform to bring together clinicians, scientists and researchers from all oncology disciplines to exchange ideas, promote multidisciplinary care and address the educational and professional development interests of our attendees. Scientific and educational sessions will cover specific clinical areas including breast, central nervous system, gastrointestinal, genitourinary, gynecologic, head and neck, immunotherapy, lymphoma, musculoskeletal, pediatric, sarcoma and thoracic cancers.

2021 ASTRO Annual Meeting (Videos) Topics: 

– 1. Digital XP Panel 01 Digital XP Panel 01 – A Primer on Clinical Trial Design to Interpret and Translate Findings to Patient Care
– 2. PRO 01 PRO Re-Irradiation
– 3. PRO 02 (INTERACTIVE) PRO RO Model, Quality Program and Socioeconomic Updates for 2022
– 4. PRO 03 Central Nervous System Case Based Discussion
– 5. PRO 04 Lung Cancer Case Based Discussion
– 6. PRO 05 ASTRO PRO Session – Prostate Oligometastases Panel Discussion
– 7. PRO 06 (INTERACTIVE) Practical Radiation Oncology Gastrointestinal Cancer Session
– 8. International 01 Latin American ASTRO
– 9. PRO 07 (INTERACTIVE) PRO Update on GYN Case Studies, Updates and Soup to Nuts Discussion of Intermediate to Advanced Cervical and Endometrial Cancer
– 10. ARRO 01 (INTERACTIVE) ARRO Annual Seminar
– 11. PRO Welcome 01 PRO Program Welcome Day 1
– 12. Digital XP eCon 01 eContouring for Gastrointestinal Cancer
– 13. Panel 04 (Live SA-CME) Challenging Cases in Breast Cancer
– 14. Panel 03 (INTERACTIVE) Palliative Radiotherapy in Pediatric Patients – What Can We Learn From Adult-Derived Evidence-
– 15. EDU 01 Multidisciplinary Management of Very High Risk to Oligometastatic Prostate Cancer
– 16. Panel 01 (Live SA-CME) Challenging Cases in Cervix Cancer
– 17. EDU 03 Updates on Brain Stereotactic Radiosurgery for Benign Conditions
– 18. EDU 02 ASTRONCI Diversity Symposium – Physician Driven Social Change A Historical Perspective and Opportunities for Radiation Oncologists
– 19. International 03 Bridging the Gap Highlighting Efforts to Build Radiation Oncology Capacity Globally
– 20. Panel 05 Professional Chameleons Embracing New Roles in Medical Physics to Advance Person-Centered Care
– 22. PRO 08 Practical Radiation Oncology – Breast Cancer Session
– 23. PRO 09 (INTERACTIVE) Intermediate Risk Prostate Cancer From Consult Through Follow Up
– 24. Digital XP Panel 02 Digital XP Panel 02 – Managing Radiotherapy-Induced Symptoms; Practical Evidence-Based Strategies for the Radiation Oncologist
– 25. PRO 10 (Live SA-CME) Management of a Tonsil Cancer Patient From Work-up Through Late Radiation Toxicity
– 26. SS 01 Breast 1 – Techniques and Toxicity
– 27. QP 02 CNS 2 – Brain Response to Radiation and Other Topics
– 28. QP 03 GI 2 – Bugs and Drugs but No Humbugs in GI Radiotherapy
– 29. QP 04 Hem 2 – The Evolving Role of Radiation in Indolent Lymphomas
– 30. SS 02 Lung 1 – Integration of Immunotherapy and Radiation Therapy for Non-Small Cell Lung Cancer
– 31. SS 03 Bio 1 – Genomic and Molecular Biomarkers
– 32. QP 01 Phys 6 – Imaging Technology and Applications
– 33. International 02 ASTROESTRO Joint Session – Spatially Fractionated Radiotherapy-Techniques and Benefits
– 34. CT 01 Clinical Trials and Innovation
– 35. Presidential Symposium Introduct Presidential Symposium Advancing Person Centered Care Through Innovation – Introduction
– 36. PS 01 Presidential Symposium Session I – Harnessing Scientific Innovation to Improve Person-Centered Care
– 37. PS 02 Presidential Symposium Session II – Digital Health to Improve Patient Outcomes and Experience
– 38. PS 03 Presidential Symposium Session III – Aiming to Improve Patient Outcomes with Paradigm Changing Applications of Radiotherapy
– 39. PS 04 Presidential Symposium Session IV – Debate Randomized Clinical Trials vs Real World Data
– 40. PS 05 Presidential Symposium Session V – Final Wrap Up
– 41. Digital XP ST 01 Digital XP Storytelling 01 – Resilience and Self-Care From Peer to Peer
– 42. Digital XP ARRO Welcome Digital XP ARRO Chair Welcome Address
– 43. Digital XP ARRO 01 Digital XP ARRO 01 – Negotiating Employment Contracts
– 44. Welcome 01 Welcome to ASTRO’s Annual Meeting
– 45. International 05 (INTERACTIVE) Joint ASTRO-RUSSCO Session Medice, cura aegrotum, sed non morbum Emotional and Mental Health of Cancer Patients Undergoing Treatment
– 46. EDU 07 (INTERACTIVE) Quality Payment Program Update
– 47. EDU 08 2022 Radiation Oncology Coding and Coverage Update
– 48. EDU 04 (Live SA-CME) Radiation Oncologists’ Role in Promoting Person-Centered Care in the Curative and Palliative Settings
– 49. Panel 10 (INTERACTIVE) Mitigating Bias in Recruitment Attracting a Diverse, Dynamic Workforce to Sustain the Future of Radiation Oncology
– 50. EDU 05 (INTERACTIVE) Improving Quality of Life and Outcomes for Patients With Upper GI Cancers With Advancements in Treatment Technology
– 51. Joint 02 (Live SA-CME) ASTROIOTN Joint Session – RadiationImmunotherapy Combinations – Clinical Highlights and Case Discussion
– 52. Special Session 02 (INTERACTIVE) Paint by MRI A New Era in Biologically-Driven Adaptive Radiotherapy
– 53. EDU 06 Radiation in the Multidisciplinary Management of Thymic Malignancies
– 54. Panel 09 PENTEC Pediatric Normal Tissue Effects in the Clinic An international Collaboration – Task Force Results, Knowledge Gaps, and the Path Forward
– 55. Panel 07 Quantitative Imaging for Support of Radiation Oncology-Focused Clinical Trials in the US and Abroad
– 56. EDU 10 (Live SA-CME) Debating the Best Treatment for Early Prostate Cancer Surgery, Radiation, or Neither
– 57. EDU 09 The New Virtual Reality Improving Care Through Telemedicine and Understanding Its Impact on Patients, Policy, and Payment
– 58. EDU 12 Innovative Biologic Approaches to Personalize RT for Metastatic Breast Cancer
– 59. EDU 11 Creating Equitable and Inclusive Spaces for Black, Indigenous, and Latinx Trainees, Residents, and Faculty Opportunities and Pathways
– 60. Panel 08 AI-Empowered Clinical Decision Support for Better Treatment Outcomes
– 61. International 04 Novel Educational Opportunities in the IT-Enabled World
– 62. Panel 06 ASTRO’s First Evidence-Based Guideline on Soft Tissue Sarcoma in Adults Case-Based Implementation of Recommendations
– 63. QP 05 Breast 3 – Breast Cancer Quick Pitch
– 64. SS 07 CNS 1 – Clinical Trials and Novel Approaches to Malignant Brain Tumors
– 65. QP 07 DHI 2 – Evolution of Machine Learning Guided Decision Frameworks in Clinical Practice and Research
– 66. SS 08 DEIH 1 – Diversity, Equity and Inclusion in Healthcare
– 67. SS 11 GI 1 – Trust but Verify Quality Assurance and Quality of Life in GI Cancers
– 68. SS 05 GYN 1 – Advancements in Gynecological Treatment in the Era of Personalized Medicine
– 69. SS 10 H&N 1 – Improving Outcomes for Head and Neck Cancer Patients
– 70. QP 09 HSR 2 – Global Oncology
– 71. QP 11 Lung 3 – Cardiac Dose Effects in Locally Advanced Lung Cancer Patients
– 72. QP 08 Palliative 2 – Improving Symptoms Through Supportive Care and Palliative Radiotherapy
– 73. QP 06 Patient Safety 2 – Communication, Telehealth and Safety in a Pandemic and Beyond
– 74. SS 12 Sarcoma 1 – Individualization of Radiotherapy Based Treatment for Sarcoma and Cutaneous Malignancy
– 75. QP 10 Bio 5 – Immunotherapy, Immune Response and Inflammation II
– 76. QP 12 Bio 6 – Normal Tissue Injury
– 77. SS 06 Phys 1 – Best of Physics
– 78. SS 09 Phys 2 – Ultra-High Dose Rate Radiotherapy (FLASH)
– 79. SS 04 Phys 4 – Imaging for Response Assessment
– 80. SS 13 DHI 3 – The U-Net & You Is Segmentation a Solved Problem-
– 81. PL 01 Plenary Session
– 82. Keynote Address 01 Moral Injury and Choosing Change
– 83. Special Session 01 (INTERACTIVE) The Science of Hope Why and How To Approach the Most Difficult Situations in Oncology
– 84. Presidential Address The Time for Change is Now
– 85. ST 01 Storytelling 1 – Parental Leave Navigating the Pressures of Starting a Family and Radiation Oncology Practice andor Training
– 86. SH 01 Science Highlights 1 – Genitourinary Cancer
– 87. SH 02 Science Highlights 2 – Diversity, Equity, and Inclusion in Healthcare
– 88. Digital XP eCon 02 eContouring for Oligometastatic Disease
– 89. Digital XP EDU 01 Digital XP SA-CME EDU 01 – Patient Focused Treatment of Gynecologic Cancers
– 90. Digital XP ST 02 Digital XP Storytelling 02 – Beneath the Treatment Mask The mess that mortality makes of the mind
– 91. Digital XP SH 07 Digital XP Science Highlights 07 – Breast
– 92. Digital XP ARRO 02 Digital XP ARRO 02 – Optimal Strategies to Effectively Transition to Junior Faculty
– 93. Digital XP ARRO 03 Digital XP ARRO 03 – Private Practice Valuation and Billing Basics
– 94. Digital XP SH 09 Digital XP Science Highlights 09 – Digital Health Innovation
– 95. Digital XP SH 08 Digital XP Science Highlights 08 – Biology
– 96. Digital XP SH 10 Digital XP Science Highlights 10 – Health Services Research
– 97. Digital XP SH 11 Digital XP Science Highlights 11 – Palliative
– 98. Digital XP SH 12 Digital XP Science Highlights 12 – Patient Reported Outcomes
– 99. Digital XP SH 13 Digital XP Science Highlights 13 – Patient Safety
– 100. Digital XP SH 14 Digital XP Science Highlights 14 – Pediatrics
– 101. Panel 15 (INTERACTIVE) Challenging Cases in GU Malignancies
– 102. SS 19 Palliative 1 – Improving Outcomes and Selection of Patients for SBRT in the Oligometastatic Setting and Beyond
– 103. EDU 18 (INTERACTIVE) Priming the Immune System Prior to CAR T Cell Therapy An Emerging Role of Radiation
– 104. Panel 11 Warning The COVID-19 Pandemic May Be – IS Hazardous to Your Mental Health
– 106. Joint 03 ASTROSPRO Joint Session – Challenging Cases in Palliative Care
– 107. Panel 14 Clinical Translation of FLASH Radiotherapy
– 108. EDU 14 (Live SA-CME) Challenging Cases in GI Malignancies
– 109. Panel 27 Judicious Use of SRS and HSRT in the Management of Limited Large Brain Metastases
– 110. EDU 16 (INTERACTIVE) Novel Radiotherapy Approaches in Stage IV NSCLC Consolidation, Oligometastases, and Oligorecurrences
– 111. Panel 13 Real-World Data and Real-World Evidence in Radiation Oncology An ASTRO-ASCO Jointly Sponsored Session
– 112. EDU 17 Leveraging the Power of Radiation Therapy to Modulate Anti-Tumor Immunity
– 113. Panel 16 (Live SA-CME) ASTRO’s First Evidence-Based Clinical Practice Guidelines on Radiation Therapy for Primary Liver Cancers
– 114. Panel 17 (INTERACTIVE) Challenging Cases in Patient Safety Leveraging RO-ILS Events to Improve Patient Treatment and Experience
– 115. EDU 15 Hypoxia Back in the Spotlight
– 116. Panel 12 (Live SA-CME) Recent Developments in the Prediction of Clinical Outcomes Data in Radiation Oncology
– 117. SS 21 Breast 2 – Biology and Outcomes
– 118. SS 20 DHI 1 – Clinical Applications of Big Data Informatics and Machine Learning
– 119. SS 15 GU 1 – Biomarkers and Salvage RT
– 120. QP 14 GU 3 – GU Smorgasbord
– 121. QP 15 GYN 2 – Clinical Innovation in Gynecologic Cancers
– 122. QP 13 Hem 3 – Pulling the Chestnut Out of the Fire Treating Relapsed Lymphoma
– 123. SS 18 Bio 2 – Experimental Therapeutics
– 124. SS 22 Bio 3 – Immunotherapy, Immune Response and Inflammation
– 125. SS 17 Phys 3 – Novel Planning and Treatment Techniques
– 126. SS 14 Phys 5 – Image Guidance and Motion Management
– 127. Keynote Address 02 The Choices that Matter
– 128. Special Session 03 Awards Ceremony
– 129. Special Session 04 ASTROSNMMI Joint Session – Prostate Cancer Molecular Imaging and Radiotheranostics
– 130. SH 03 Science Highlights 3 – Head and Neck Cancer
– 131. SH 04 Science Highlights 4 – Gynecologic Cancer
– 132. Digital XP eCon 03 eContouring for Gynecologic Cancer
– 133. Digital XP Keynote Illuminating the Dark Space of Healthcare with Ambient Intelligence
– 134. Digital XP ARRO 04 Digital XP ARRO 04 – Applied Global Oncology Challenges and Opportunities
– 135. Digital XP ARRO 05 Digital XP ARRO 05 – Bridging Academia and Industry for Medical Care Presentations by ASTRO-Industry Radiation Oncology Research Training Fellows
– 136. Digital XP SH 15 Digital XP Science Highlights 15 – Sarcoma
– 137. Digital XP SH 16 Digital XP Science Highlights 16 – CNS
– 138. Digital XP SS 01 Digital XP Special Session 01 – Accelerating Precision Radiation Oncology through Advanced Computing and Artificial Intelligence
– 139. Digital XP ST 03 Digital XP Storytelling 03 -What Happens When Physicists Get Involved In Direct Patient Care-
– 140. Panel 20 Molecular Biomarkers and Tumor-Free DNA in HPV-Associated Oropharyngeal Cancer and Implications for Future Clinical Trials
– 141. EDU 24 Transforming Radiation Therapy for Lymphomas in 2021 Embracing Change to Achieve More Comfort, More Safety, and Better Outcomes
– 142. Joint 04 (INTERACTIVE) ASTROSociety for Neuro-Oncology Joint Session – Glioma Controversies Patient-Focused Case-Based Discussion
– 143. Panel 28 Adaptive Radiation Therapy With Artificial Intelligence The Emerging Technologies and Clinical Translation
– 144. EDU 19 (INTERACTIVE) Practical Management of Vulvar and Vaginal Cancers Standard and Challenging Scenarios
– 145. EDU 22 How to Manage the Complex Needs of Pelvic Radiotherapy Survivors
– 146. EDU 21 Biological Intelligence in Oligometastases Are We There Yet-
– 147. Panel 22 From Art to Science – The Rise of Automation in Treatment Planning
– 148. EDU 23 Optimizing the Use of Patient-Reported Outcomes in Research and Practice
– 149. Panel 25 Why We Disagree Clinical Trial Interpretation and Philosophies From Frequentist, Bayesian, and AI Perspectives
– 150. Panel 24 Exploring mHealth and Wearables in Oncology Opportunities and Challenges
– 151. Panel 26 Financial Toxicity in Radiation Oncology Impact for Our Patients and for Practicing Radiation Oncologists
– 152. Panel 19 (Live SA-CME) Difficult Cases in Small Cell Lung Cancer
– 153. EDU 25 (INTERACTIVE) Updates in Locoregional Skin Cancer Management
– 154. Panel 21 Advances in Image-Guided Adaptive Radiotherapy
– 155. EDU 26 Radiation, Autophagy, and Senescence in Tumor Response Mechanisms and Clinical Implications
– 156. QP 17 GI 3 – Where Are We Going With Pancreatic Cancer Radiotherapy- Novel Biomarkers and Dosing Strategies
– 157. SS 25 GU 2 – Intermediate and High Risk Disease
– 158. QP 18 H&N 2 – Head and Neck Cancer in 2021 Updates and New Directions
– 159. SS 23 HSR 1 – Best of Health Services Research
– 160. SS 26 Hem 1 – Enhancing Efficacy and Reducing Toxicity for Patients With Hematologic Malignancies
– 161. SS 30 Lung 2 – Individualized Radiotherapy Approaches for Lung Cancer
– 162. SS 24 Patient Reported Outcomes 1 – The Heart of Person Centered Care
– 163. SS 29 Patient Safety 1 – How to Stay Calm and Carry On in a Pandemic
– 164. SS 27 Peds 1 – Improving the Therapeutic Ratio in Pediatric Malignancies
– 165. SS 28 Bio 4 – Cancer Biology
– 166. QP 16 Phys 7 – Dose Response Analysis and Novel Treatment Technology
– 167. ST 02 Storytelling 02 – Promoting Women and Underrepresented Minorities as Essential Leaders of Research
– 168. SH 05 Science Highlights 5 – Lung Cancer
– 169. SH 06 Science Highlights 6 – Gastrointestinal Cancer
– 170. CB 01 Cancer Breakthroughs
– 171. Digital XP EDU 02 Digital XP SA-CME EDU 02 – Integration of Surgery in the Multidisciplinary Care of Head and Neck Cancer Focus on Oral Cavity, Larynx, and Hypopharynx Cancers
– 172. Digital XP ST 04 Digital XP Storytelling 04 – Endpoints-PRO That matters to Patients
– 173. Digital XP SH 17 Digital XP Science Highlights 17 – Hematologic Cancers
– 174. Digital XP SH 18 Digital XP Science Highlights – Physics

Release Date : October 23-24, 2021